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Introduction
Vanadium is a trace transition metal which has 
been shown to have insulin-mimetic actions on
mammalian cells in culture (Smith 1983, Lau et al.
1988, Mountjoy & Flier 1990, Wang & Scott 1992,
1994, Chen & Chan 1993, Cortizo & Etcheverry
1995). Two kinds of vanadium effects have been
described in cultured cells: metabolic or short time
actions; and mitogenic or chronic effects (Schechter
1990, Schechter & Shisheva 1993). Vanadate, one of
the major chemical forms of vanadium in living
systems, has been postulated to exert its actions via
the inhibition of tyrosine phosphatase (PTPase)
(Gresser et al. 1987, Gresser & Tracey 1990). By
binding to their specific receptors, growth factors
induce phosphorylation of these receptors and
thereby promote cell proliferation (Lau et al. 1989).
The bioactivity of different vanadium compounds
(V (V) and V (IV) derivatives) has been tested on
several cell types. In BALB/3T3 cells it has been
demonstrated that vanadate shows strong cytotoxi-
city and causes morphological transformation of the
cells (Sabbioni et al. 1993). On the other hand, vana-
dium (IV) shows a less toxic effect in this cell line
(Sabbioni et al. 1991). It has been shown by electron
paramagnetic resonance (EPR) spectroscopy that
vanadate reduces to vanadyl inside the cells, this
being a protective mechanism to avoid cytotoxicity
(Sabbioni et al. 1992). Pervanadates, a group of
vanadium (V) derivatives, have shown stronger
effects than vanadate in adipocytes (Fantus et al.
1989, Lönnroth et al. 1993, Shisheva & Shechter
1993), HL-60 cells (Bourgoin & Grinstein 1992),
skeletal muscle (Leighton et al. 1991) and UMR106
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Vanadium compounds are shown to have a mitogenic effect on fibroblast cells. The effects of vanadate,
vanadyl and pervanadate on the proliferation and morphological changes of Swiss 3T3 cells in culture are
compared. Vanadium derivatives induced cell proliferation in a biphasic manner, with a toxic-like effect at
doses over 50 mM, after 24 h of incubation. Vanadyl and vanadate were equally potent at 2.5–10 mM. At 
50 mM vanadate inhibited cell proliferation, whereas slight inhibition was observed at 100 mM of vanadyl.
At 10 mM pervanadate was as potent as vanadate and vanadyl in stimulating fibroblast proliferation, but no
effect was observed at lower concentrations. A pronounced cytotoxic-like effect was induced by pervana-
date at 50 mM. All of these effects were accompanied by morphological changes: transformation of fibro-
blast shape from polygonal to fusiform; retraction with cytoplasm condensation; and loss of lamellar
processes. The magnitude of these transformations correlates with the potency of vanadium derivatives to
induce a cytotoxic-like effect: pervanadate > vanadate > vanadyl. These data suggest that the oxidation state
and coordination geometry of vanadium determine the degree of the cytotoxicity.
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cells (Cortizo & Etcheverry 1995). Nevertheless,
pervanadates may have toxic effects on certain
cellular types.
The aim of this study was to compare the mito-
genic effect and morphological changes induced on
Swiss 3T3 fibroblasts by different vanadium
compounds.
Materials and methods
Materials
Vanadium (IV)-oxide sulfate (vanadyl sulfate) was
obtained from Merck (Darmstadt, Germany), o-vanadate,
catalase and p-nitrophenylphosphate (pNPP) were
obtained from Sigma (St. Louis, MO, USA). Tissue
culture material was provided by Corning (Princeton, NJ,
USA). Dulbecco’s modified Eagle’s medium (DMEM)
and trypsin were supplied by Gibco (Gaithersburg, MD,
USA)  and fetal bovine serum (FBS) by Gen (Buenos
Aires, Argentina).
Vanadium compounds and solution preparations
Vanadate solution (100 mM) was prepared from sodium
o-vanadate (Sigma). Vanadium (IV)-oxide sulfate
(vanadyl sulfate) was obtained from Merck and dissolved
in distilled water to obtain a 100 mM fresh solution. In the
concentration range used (2.5–100 mM) the culture
medium has enough buffer capacity to maintain a pH
value of 7.4. Pervanadate was prepared according to
Trudel et al. (1991). Briefly, equivalent amounts of 10 mM
o-vanadate and 10 mM H2O2 were mixed at room temper-
ature for 15 min. Then, 200 mg ml–1 catalase were added
to eliminate the excess H2O2. This procedure resulted in
the generation of the peroxidized form of vanadate, which
is stable for 2 h without further addition of H2O2 (Kadota
et al. 1987). Controls for these experiments consisted of a
similar preparation in the absence of vanadate. No statis-
tical differences were found in comparison with the cells
incubated in DMEM alone (basal conditions). All the
solutions were added to the culture medium immediately
after their preparation.
Cell culture
Swiss 3T3 cells were cultured in DMEM supplemented
with 100 U ml–1 penicillin, 100 mg ml–1 streptomycin and
10% FBS in a humidified atmosphere of 95% air/5% CO2.
Cells were subcultured by trypsin treatment when they
became 70% confluent. For experiment, about 2.5 × 104
cells per ml were plated into 24-well plates. After the cells
had reached 70% confluence, the monolayer was washed
with DMEM without serum and incubated in 0.5 ml
DMEM plus various concentrations of vanadium
compounds for 24 h.
Cell proliferation assay
A mitogenic bioassay was carried out as described previ-
ously (Cortizo & Etcheverry 1995). The crystal violet fixed
by cells was quantified at 540 nm after an extraction proce-
dure. In order to confirm that the colorimetric bioassay
correlated with cell proliferation, the relationship between
cell number per well and the absorbance at 540 nm was
examined. Cell number was determined by trypsinization
of wells and counting the cells with a Neubauer chamber.
Figure 1 demonstrates a strong linear correlation between
the total cell number per well and the absorbance at 540
nm corrected by sample dilution over the range of cell
numbers obtained by stimulation with different agents. In
the experiments, cells were incubated with different vana-
dium compounds at the doses and periods indicated in the
figure legends.
Morphology
Cells were plated into a 35 mm dish at a density of 2 × 104
cells per dish. After 24 h, cells were washed with DMEM
and incubated in fresh DMEM plus different vanadium
compounds (50 mM) for an additional 24 h. Cells were then
washed and stained with crystal violet as before and the
morphological changes were examined.
Statistical methods
Data are expressed as the mean ± SEM. Statistical differ-
ences were analysed using Student’s t-test or analysis of
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Figure 1. Correlation between the total cell number 
per well and the optical density at 540 nm corrected by
dilution of cell extract (crystal violet assay). j,d values
represent two independent experients performed by 
triplicate.
variance when suitable. Linear regression analysis was
performed by Pearson’s correlation coefficient.
Results
Effect of vanadium compounds on cell 
proliferation
To assess the effect of vanadium derivatives on
fibroblast proliferation, the crystal violet bioassay
was performed. All vanadium compounds stimu-
lated cell progression in a narrow range of concen-
tration after 24 h of culture.
Vanadyl increased Swiss 3T3 fibroblast prolifera-
tion in a biphasic manner (Figure 2). Low doses
(2.5–10 mM) significantly increased cell growth in the
range 131–134% of basal (P < 0.001). No effect was
observed at higher concentrations (up to 100 mM).
At the 100 mM dose, a slight but significant inhibi-
tion was observed (80% of basal, P < 0.05).
The incubation of cells with vanadate induced 
cell proliferation in a biphasic manner, like vanadyl, 
with a maximum between 2.5 and 10 mM (125% of 
basal, P < 0.001) (Figure 3). However, doses
between 50 and 100 mM strongly inhibited cell prolif-
eration (63–54% of basal, P < 0.01–0.001).
Pervanadate caused stimulation of cell growth at
10 µM (118% of basal, P < 0.01) (Figure 4). Its main
effect was a dose-response inhibition on mitogenesis
between 50 and 100 mM (33–9% of basal, P < 0.001).
The effectiveness of vanadium compounds in
stimulating cell proliferation was analysed. At low
doses (2.5 and 5 mM) vanadate and vanadyl, but 
not pervanadate, were similarly potent mitogens.
However, the 10 mM concentration of pervanadate
induced a stimulation statistically comparable with
the other two derivatives. On the other hand,
comparison of the toxic-like effect, as assessed by
cell growth inhibition, suggests that pervanadate was
the most toxic agent. At 50 mM it inhibited 70% of
the basal proliferation, whereas the effect of vana-
date was only 37% (P < 0.01, pervanadate versus
vanadate). Under similar conditions no effect was
observed with the vanadyl cation.
Morphological changes induced by vanadium
compounds
In the Swiss 3T3 cells exposed to 50 mM of vana-
dium compounds, the extent of the morphological
changes in cells was evident after 24 h.
Control cultures showed polyhedrical or stellate
fibroblasts with slender lamellar expansions (Figure
5A). These expansions appeared to be joined to each
other among neighbour cells. The nuclei showed
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Figure 2. Effect of vanadyl cation on cell proliferation.
Data are expressed as % over basal and indicate the means
± SEM (n = 12). P values versus basal are: # P < 0.05, 
*P < 0.001.
Figure 3. Effect of vanadate on cell proliferation. Data
are expressed as % over basal and indicate the means ±
SEM (n = 12). P values versus basal are: # P < 0.01, 
*P < 0.001.
moderately thick chromatin granules. The perinu-
clear cytoplasm had numerous organelles and
vacuoles, while the exoplasm was diffuse and homo-
geneous.
The fibroblasts from vanadyl-treated cultures
displayed slight changes with respect to those from
control cultures (Figure 5B). In general, cells were
less polyhedrical, more fusiform, showing denser and
less extended cytoplasmic processes. The nucleus
contained less defined chromatin granules.
Cells cultured with vanadate showed clear
morphological changes (Figure 5C). Fibroblasts
were fusiform in shape, had a more condensed cyto-
plasm and less processes, with clearly defined
borders. They seemed to be smaller than the fibro-
blasts from control cultures. A few stellate-shaped
cells with lamellar expansions were also found in
these cultures.
Cultures treated with pervanadate showed the
most pronounced morphological changes (Figure
5D). Cells were long, fusiform, very dense, and
presented well-defined borders. These fibroblasts
displayed few and fine processes and showed a very
dense cytoplasm.
These results seem to indicate that vanadium (V)
derivatives are stronger morphological transformers
for Swiss 3T3 fibroblasts than are vanadium (IV)
compounds.
In addition, a morphological study was carried out
at 10 mM concentration of the three vanadium deriv-
atives. This dose was chosen because it induced the
maximal stimulation of cellular proliferation. The
results showed that cells incubated with vanadyl and
vanadate were not different from the control
cultures (results not shown). Cultures treated with
10 mM pervanadate showed a very few cells with
more condensed cytoplasm, but with a general
morphology similar to the control.
In order to get a deeper insight into the cytotox-
icity of vanadium compounds, a time course of 
vanadate (50 mM) was carried out, studying in
parallel the morphological and proliferative modifi-
cations. As early as 6 h of culture, a few fusiform
cells could be seen among normal polygonal cells
(results not shown). The monolayer incubated for
12 h with vanadate showed an increase in the
proportion of fusiform cells without processes, and
this tendency was more pronounced after 24 and 36
h. These experiments suggest that the morpholog-
ical changes with 50 mM vanadate evolved as a func-
tion of the incubation time. On the other hand, 
the proliferative inhibition was only observed after
24 h of incubation (73% of basal, P < 0.05). No
differences were found after 6 h (98% of basal) or
12 h (84% of basal) incubation with vanadate. This
study suggests that the inhibition of cell growth 
is delayed in comparison with the morphological
alterations.
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Figure 4. Effect of pervanadate on cell proliferation.
Data are expressed as % over basal and indicate the means
± SEM (n = 9). P values versus basal are: # P < 0.01, 
*P < 0.001.
Figure 5. Effect of vanadium compounds on Swiss 3T3
fibroblast morphology. Cells were incubated in DMEM
(control, A), or µM of vanadyl (B), vanadate (C) or
pervanadate (D) for 24 h. After this period, cells were
stained with crystal violet. Objective × 40.
Discussion
It has been shown previously that vanadate stimu-
lates DNA synthesis in several cell lines (Smith 1983,
Mountjoy & Flier 1990, Davidai et al. 1992, Cortizo
& Etcheverry 1995). This effect is supposed to be
mediated by the inhibition of PTPases, which in turn
regulate the levels of phosphoproteins. Thus, vana-
date mimics the effects of insulin and insulin-like
grown factors (Lau et al. 1989). The present study
provides new experimental evidence for the prolif-
eration and morphological transformation induced
by vanadium compounds in fibroblasts in culture.
The oxidation state and coordination geometry of
vanadium in the different derivatives are also consid-
ered in relationship to their bioactivity.
The three vanadium derivatives tested showed a
biphasic effect on Swiss 3T3 fibroblast growth. At
low concentrations, the maximum stimulatory effect
was obtained with 10 mM of the three vanadium
compounds. On the other hand, vanadyl, vanadate
and pervanadate behaved differently as inhibitors of
cellular proliferation. At 50 mM concentration,
vanadyl did not show cytotoxic-like effects, whereas
vanadate and pervanadate strongly inhibited cell
development. Furthermore, vanadate showed a
weaker cytotoxic effect than pervanadate.
The speciation of the peroxo compounds formed
under our experimental conditions were not deter-
mined. According to other authors, the species and
structures in solution have not been characterized
(Stankiewicz & Tracey 1995). Nevertheless, accord-
ing to this reference, we think that the two predomi-
nant species in solution are mono- and diper-
oxovanadates. Diperoxovanadates interact with dif-
ferent ligands forming strong monodentate com-
plexes. On the other hand, mono-peroxovanadates
tend to generate multidentate products. However,
the way in which this behaviour is reflected in the tox-
icity and other effects in the cell cultures is still
unknown.
The observed effects of vanadium compounds on
cellular proliferation were clearly associated with the
morphological transformation of fibroblasts. We
selected a concentration of 50 mM for these studies
since at this dose, clear differences in cell prolifera-
tion were found among the three vanadium deriva-
tives. In order to facilitate the observation of the
morphological changes, cells were also plated on a
35 mm dish at a lower cell density than in the prolif-
eration studies. Vanadium compounds induced the
cells to display an unusual fusiform aspect, with few
processes and condensed cytoplasm. These changes
were more important in the case of pervanadate and
vanadate; vanadyl showing the least effect. Other
authors have previously demonstrated that vanadate
induced phenotypic transformation in different cell
lines (Klarlund 1985, Mountjoy & Flier 1990,
Sabbioni et al. 1993); our studies confirm their results
and demonstrate for the first time that pervanadate
influences cellular morphology. Moreover, no direct
evidence of a relationship between morphological
and biochemical changes has previously been given.
Our results suggest a direct correlation between the
cytotoxic-like effects and the morphological trans-
formation of the cells. This assumption is supported
by the following observations: (a) vanadyl induces
the weakest cytotoxic effect and also the weakest
morphological transformation; (b) pervanadate
causes a drastic decrease in the cell proliferation and
strongly affects cellular morphology; and (c) 10 mM
of any vanadium derivatives, a dose which stimu-
lates cell growth, does not produce morphological
transformations.
In BALB/3T3 cells, Sabbioni et al. (1991) studied
the cytotoxicity and morphological transforma-
tions exerted by vanadium (V) and (IV). Whereas
at 3–10 mM vanadyl did not transform cells, vana-
date showed neoplastic transformation. In our Swiss
3T3 culture system, 2.5–10 mM vanadate stimulated
cell growth. On the other hand, Sabbioni et al. (1991)
also showed that vanadyl exerted a cytotoxic effect
at doses at which no morphological transformations
were induced. On the contrary, our studies show
morphological but no proliferative changes at 50 mM
vanadyl. Altogether, these observations suggest that
the bioactivity of the vanadium compounds would
depend, at least in part, on the cellular type used in
the in vitro study.
Taking into account the vanadium oxidation state,
the experimental data suggest that vanadium (V)
compounds are more cytotoxic than vanadium (IV)
at a concentration of 25 mM. Vanadates are usually
pentacoordinated assuming a tetahedral structure
but can convert to a trigonal bipyramid. Pervan-
adates show a coordination number of six, seven or
eight, adopting the pentagonal bipyramid form
(Stankiewicz & Tracey 1995). These features allow
us to suggest that the coordination geometry may
play a role in the deleterious effects of vanadium
compounds in this cell line. Another possibility of
the observed differences between the two vanadium
(V) compounds tested could be due to a greater toxi-
city of the peroxo derivatives. This toxicity may be
related to the ability to act as an oxidant of cellular
thiols (Stankiewicz et al. 1995). Peroxovanadates are
more potent oxidizing agents than vanadate, espe-
cially with regard to cysteine residues of some
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enzymes. Such oxidations may led to irreversible
enzyme inactivation. Hydrogen peroxide has been
demonstrated to have similar insulin-mimetic effects
to vanadate (Stankiewicz & Tracey 1995). However,
the pervanadates show a significant enhancement of
these effects. The mechanism of the toxic effect 
of vanadate is not currently known, even though
inhibition of PTPases has been suggested (Lau et al.
1989). Using EPR spectroscopy, it has been shown
that vanadate is reduced to vanadyl upon entry into
cells (Degani et al. 1981, Heinz et al. 1982, Willsky
& Dosch 1986, Sabbioni et al. 1993). By this biotrans-
formation cells become protected from the toxic
action of vanadate. The way in which cells might
handle other vanadium derivatives, such as pervana-
date, is still unknown and requires further investi-
gation. Our results suggest that if the bio-
transformation mechanism is operative in fibrob-
lasts, it is not efficient enough to prevent the toxi-
city of pervanadate. Thus, the higher toxicity of
pervanadate as compared with vanadate could
derive from the detoxifying pathway into the cells.
In brief, our results show that: (a) vanadium
compounds induce mitogenic effects correlated with
morphological transformations; (b) the morpholog-
ical changes precede the proliferative alterations;
and (c) the oxidation state and coordination geom-
etry of the vanadium compounds could determine
the magnitude of the cytotoxicity. This selectivity is
likely to be related to the mechanism by which cells
handle the metabolism of vanadium derivatives.
Acknowledgements
The authors are grateful to Professor Dr Cesar L.
Gómez Dumm for help in the morphological studies
and to Miss Nyria Fenoglio for reviewing the manu-
script language. VCS is a fellow from CICPBA,
AMC is a member of the Carrera del Investigador,
CICPBA, Argentina and SBE is a member of the
Carrera del Investigador, CONICET, Argentina.
This work was supported by grants from Facultad
de Ciencias Exactas, UNLP and Universidad
Nacional de La Plata, Argentina.
References
Bourgoin S, Grinstein S. 1992 Peroxides of vanadate
induce activation of phospholipase D in HL-60 cells.
Role of tyrosine phosphorylation. J Biol Chem 267,
11908–11916.
Chen Y, Chan TM 1993 Orthovanadate and 2,3-
dimethoxy-1,4-naphthoquinone augment growth factor-
induced cell proliferation and c-fos gene expression in
3T3-L1 cells. Arch Biochem Biophys 305, 9–16.
Cortizo AM, Etcheverry SB. 1995 Vanadium derivatives
act as growth factor mimetic compounds upon differ-
entiation and proliferation of osteoblast-like UMR106
cells. Mol Cell Biochem 145, 97–102.
Davidai G, Lee A, Schuartz Y, Hazum E. 1992 PDGF
induces tyrosinephosphorylation in osteoblast-like cells:
relevance to mitogenesis. Am J Physiol 263, E205–
E209.
Degani H, Gochin M, Karlish JD, Shechter Y. 1981
Electron Paramagnetic Resonance Studies and Insulin-
like Effects of Vanadium in Rat Adipocytes.
Biochemistry 20, 5795–5799.
Fantus G, Kadota S, Deragon G, Foster B, Posner B. 1989
Pervanadate [peroxide(s) of vanadate] mimics insulin
action in rat adipocytes via activation of the insulin
receptor tyrosine kinase. Biochemistry 28, 8864–8871.
Gresser M, Tracey AS. 1990 Vanadates as phosphate
analogs in biochemistry. In: Chasteen ND, ed.
Vanadium in Biological Systems. The Netherlands:
Kluwer Academic Publishers; 63–79.
Gresser M, Tracey AS, Stankiewicz P. 1987 The interac-
tion of vanadate with tyrosine kinases and phosphatases.
Adv Prot Phosphatases 4, 35–57.
Heinz H, Rubinson KA, Grantham JJ. 1982 The transport
and accumulation of oxyvanadium compounds in human
erythrocytes in vitro. J Lab Clin Med 100, 593–612.
Kadota S, Fantus IG, Deragon G, Guyda HJ, Posner BI.
1987 Stimulation of insulin-like growth factor II
receptor binding and insulin receptor kinase activity in
rat adipocytes. Effects of vanadate and H2O2. J Biol
Chem 262, 8252–8256.
Klarlund JK. 1985 Transformation of cells by an inhibitor
of phosphatases acting on phosphotyrosine in proteins.
Cell 41, 707–711.
Lau KHW, Tanimoto H, Baylink D. 1988 Vanadate stim-
ulates bone cell proliferation and bone collagen
synthesis in vitro. Endocrinology 123, 2858–2867.
Lau KHW, Farley J, Baylink D. 1989 Phosphotyrosyl
protein phosphatases. Biochem J 257, 23–36.
Leighton B, Cooper GJS, DaCosta C, Foot E. 1991
Peroxovanadates have full insulin-like effects on
glycogen synthesis in normal and insulin-resistant
skeletal muscle. Biochem J 276, 289–292.
Lönnroth P, Eriksson JW, Posner BI, Smith U. 1993
Peroxovanadate but not vanadate exerts insulin-like
effect in human adipocytes. Diabetologia 36, 113–116.
Mountjoy KG, Flier JS. 1990 Vanadate regulates glucose
transporter (Glut-1) expression in NIH3T3 mouse
fibroblasts. Endocrinology 127, 2025–2034.
Sabbioni E, Pozzi G, Pintar A, Casella L, Garattini S. 1991
Cellular retention, cytotoxicity and morphological trans-
formation by vanadium(IV) and vanadium(V) in
BALB/3T3 cell lines. Carcinogenesis 12, 47–52.
Sabbioni E, Bonardi M, Gallorini M, et al. 1992
Application of radiotracers with high specific radio-
activity to metallotoxicological studies. J Radioanal
Nucl Chem 160, 493–503.
11111
2
3
4
5
6
7
8
9
10111
1
2
3
4
5
6
7
8
9
20111
1
2
3
4
5
6
7
8
9
30111
1
2
3
4
5
6
7
8
9
40111
1
2
3
4
5
6
7
8
9
50111
1
2
3
4111
132 BioMetals Vol 10 1997
A. M. Cortizo et al.
Sabbioni E, Pozzi G, Devos S, et al. 1993 The intensity of
vanadium(V)-induced cytotoxicity and morphological
transformation in BALB/3T3 cells is dependent on
glutathione-mediated bioreduction to vanadium(IV).
Carcinogenesis 14, 2565–2568.
Shechter Y. 1990 Insulin-mimetic effect of vanadate.
Possible implications for future treatment of diabetes.
Diabetes 39, 1–5.
Shechter Y, Shisheva A. 1993 Vanadium salts and the
future treatment of diabetes. Endeavour 17, 27–31.
Shisheva A, Shechter Y. 1993 Mechanism of pervanadate
stimulation and potentiation of insulin-activated glucose
transport in rat adipocytes: dissociation from vanadate
effect. Endocrinology 133, 1562–1568.
Smith JB. 1983 Vanadium ions stimulate DNA synthesis
in Swiss mouse 3T3 and 3T6 cells. Proc Natl Acad Sci
80, 6162–6166.
Stankiewicz PJ, Tracey AS. 1995 Stimulation of enzymes
activity by oxovanadium complexes. In: Sigel H & Sigel
A, eds. Metal Ions in Biological Systems. vol 31.
Vanadium and its Role in Life. New York: Marcel
Dekker, Inc.; 249–285.
Stankiewicz PJ, Tracey AS, Crans DC. 1995 Inhibition 
of phosphate-metabolizing enzymes by oxovana-
dium (V) complexes. In: Sigel H & Sigel A, eds. Metal
Ions in Biological Systems. vol 31. Vanadium and 
its Role in Life. New York: Marcel Dekker, Inc.;
287–324.
Trudel S, Paquet MR, Grinstein S. 1991 Mechanism of
vanadate-induced activation of tyrosine phosphoryla-
tion and of the respiratory burst in HL-60 cells. Role
of reduced oxygen metabolites. Biochem J 276, 
611–619.
Wang H Scott RE. 1992 Induction of c-jun independent
of PKC, pertussis toxin-sensitive G protein, and
polyamines in quiescent SV40-transformed 3T3 T cells.
Exp Cell Res 203, 47–55.
Wang H, Scott RE. 1994 Distinct protein tyrosine phos-
phorylation during mitogenesis induced in quiescent
SV40-transformed 3T3 T cells by insulin or vanadate. J
Cell Physiol 158, 408–416.
Willsky GR, Dosch S. 1986 Vanadium Metabolism in Wild
Type and Respiratory-Deficient Strains of S. cerevisiae.
Yeast 2, 77–85.
1
1
1
1
1
1
Vanadium compounds and Swiss 3T3 fibroblasts
BioMetals Vol 10 1997 133
